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In the title pymiridine-2,4-dione derivative, C14H16N2O2S, the
dihedral angle between the six-membered rings is 66.69 (10).
The molecule is twisted about the Cp—S (p = pyrimidine)
bond, with a C—S—C—N torsion angle of 19.57 (16). In
the crystal, adjacent molecules form inversion dimers through
pairs of strong N—H  O hydrogen bonds, generating an
R2
2(8) ring motif. The dimers are connected into chains
extending along the c-axis direction through additional N—
H  O hydrogen bonds.
Related literature
For the pharmacological activity of pyrimidine-2,4-dione
derivatives, see: Al-Abdullah et al. (2011); El-Emam et al.
(2004); Hopkins et al. (1996); Klein et al. (2001); Miyasaka et
al. (1989); Nencka et al. (2006); Russ et al. (2003); Tanaka et al.
(1995); For related pyrimidine-2,4-dione structures, see: El-
Brollosy et al. (2009); Wang et al. (2006). For hydrogen-bond
motifs, see: Bernstein et al. (1995). For reference bond lengths,






a = 11.8356 (3) A˚
b = 10.3040 (2) A˚
c = 13.3999 (3) A˚
 = 119.850 (2)
V = 1417.37 (6) A˚3
Z = 4
Cu K radiation
 = 2.03 mm1
T = 293 K






Tmin = 0.287, Tmax = 0.855
9643 measured reflections
2658 independent reflections
2450 reflections with I > 2(I)
Rint = 0.024
Refinement
R[F 2 > 2(F 2)] = 0.044




H atoms treated by a mixture of
independent and constrained
refinement
max = 0.33 e A˚
3
min = 0.39 e A˚3
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
N2—H2N2  O1i 0.84 (2) 1.98 (2) 2.815 (2) 173 (2)
N1—H1N1  O2ii 0.79 (2) 2.17 (2) 2.8988 (18) 155 (2)
Symmetry codes: (i) xþ 1;y;zþ 1; (ii) x;yþ 12; zþ 12.
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to refine
structure: SHELXTL; molecular graphics: SHELXTL; software used
to prepare material for publication: SHELXTL and PLATON (Spek,
2009).
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5-Propyl-6-(p-tolylsulfanyl)pyrimidine-2,4(1H,3H)-dione
Fatmah A. M. Al-Omary, Hazem A. Ghabbour, Ali A. El-Emam, C. S. Chidan Kumar and Hoong-
Kun Fun
S1. Comment 
Pyrimidine-2,4-diones and their related derivatives have long been known for their diverse chemotherapeutic activities 
including antiviral activity against the HIV (Miyasaka et al., 1989; Tanaka et al., 1995; Hopkins et al., 1996; El-Emam et 
al., 2004), and HSV viruses (Russ et al., 2003). In addition, potent anticancer activity was observed for several 
pyrimidine-2,4-diones (Klein et al., 2001; Nencka et al., 2006). In continuation to our interest in the chemical and 
pharmacological properties of pyrimidine and uracil derivatives (Al-Abdullah et al., 2011; El-Brollosy et al., 2009), we 
have synthesized the title compound (I) as a potential chemotherapeutic agent.
The title compound (I) is a derivative of pymiridine-2,4-dione. The heterocycle contains the structural unit CON2H2CO, 
forming the dihedral angle of 66.69 (10)° with the adjacent benzene ring. The molecule is bent (Fig. 1) at the S atom with 
a C–S–C–N torsion angle of -19.57 (16)°. The bond lengths (Allen et al., 1987) and angles in the title compound are 
within normal ranges and are comparable with those reported earlier (El-Brollosy et al., 2009; Wang et al., 2006). The 
crystal structure features for two types of intermolecular N–H···O hydrogen bonds (Table 1). Two adjacent molecules 
form inversion-related dimers through strong N2–H2A···O1 hydrogen bonds (symmetry code: -x + 1, -y, -z + 1), 
generating an R22(8) ring motif (Bernstein et al., 1995) (Fig. 2). These dimers are further connected into chains extending 
along c axis through additional N1–H1N1···O2 hydrogen bonds (symmetry code: x, -y +1/2, z + 1/2) (Fig. 2). Crystal 
stability is mainly consolidated by these hydrogen bonding interactions forming two-dimensional networks parallel to the 
bc plane.
S2. Experimental 
A mixture of 6-chloro-5-propyluracil (943 mg, 0.005 mol), p-thiocresol (621 mg, 0.005 mol) and potassium hydroxide 
(281 mg, 0.005 mol), in ethanol (10 ml), was heated under reflux for 3 h. The solvent was then distilled off in vacuo and 
the residue was washed with cold water, dried and crystallized from ethanol to yield 995 mg (72%) of the title compound 
(C14H16N2O2S) as colorless needle-like crystals. M·P.: 446–448 K.
1H NMR (DMSO-d6, 500.13 MHz): δ 0.84 (t, 3H, CH2CH3, J = 7.0 Hz), 1.38–1.40 (m, 2H, CH2CH3), 2.31 (s, 3H, Ar—
CH3), 2.44 (t, 2H, CH2CH2CH3, J = 7.0 Hz), 7.22 (d, 2H, Ar—H, J = 7.0 Hz), 7.30 (d, 2H, Ar—H, J = 7.0 Hz), 10.74 (s, 
1H, NH), 11.21 (s, 1H, NH). 13C NMR (DMSO-d6, 125.76 MHz): δ 13.73 (CH2CH3), 20.54 (CH2CH3), 22.05 
(CH2CH2CH3), 28.11 (Ar—CH3), 116.60 (pyrimidine C-5), 128.10, 130.01, 130.18, 130.55 (Ar—C), 143.84 (pyrimidine 
C-6), 150.46 (C=O), 163.19 (C=O).
S3. Refinement 
The nitrogen-bound H-atoms were located in a difference Fourier map and were refined freely. Other H atoms were 
positioned geometrically (C=H 0.93–0.97 Å) and refined using a riding model with Uiso(H) = 1.2 Ueq(C) or 1.5 Ueq(C) for 
supporting information
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methyl H atoms. A rotating group model was used for the methyl group.
Figure 1
The molecular structure of the title compound with the atom labelling scheme and 30% probability displacement 
ellipsoids. 
Figure 2
Crystal packing of the title compound, viewed along the b axis, showing the N1–H1N1···O2 and N2–H2N2···O1 






Hall symbol: -P 2ybc
a = 11.8356 (3) Å
b = 10.3040 (2) Å
c = 13.3999 (3) Å
β = 119.850 (2)°
V = 1417.37 (6) Å3
Z = 4
F(000) = 584
Dx = 1.295 Mg m−3
Cu Kα radiation, λ = 1.54178 Å
Cell parameters from 5622 reflections
θ = 3.8–69.5°
µ = 2.03 mm−1
T = 293 K
Needle, colourless
0.82 × 0.71 × 0.08 mm
supporting information
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Data collection 
Bruker APEXII CCD 
diffractometer
Radiation source: fine-focus sealed tube
Graphite monochromator
φ and ω scans
Absorption correction: multi-scan 
(SADABS; Bruker, 2009)
Tmin = 0.287, Tmax = 0.855
9643 measured reflections
2658 independent reflections
2450 reflections with I > 2σ(I)
Rint = 0.024













Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: inferred from 
neighbouring sites
H atoms treated by a mixture of independent 
and constrained refinement
w = 1/[σ2(Fo2) + (0.0707P)2 + 0.439P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.33 e Å−3
Δρmin = −0.39 e Å−3
Special details 
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used 
only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 
are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
S1 0.28497 (6) 0.53022 (5) 0.47950 (5) 0.0610 (2)
O1 0.45217 (15) 0.07980 (13) 0.58320 (11) 0.0594 (4)
N1 0.38171 (14) 0.28614 (14) 0.53086 (12) 0.0434 (3)
C1 0.35088 (16) 0.38803 (16) 0.45499 (14) 0.0426 (4)
O2 0.44741 (15) 0.24368 (14) 0.26889 (11) 0.0584 (4)
N2 0.45477 (15) 0.16770 (15) 0.42914 (12) 0.0441 (3)
C2 0.43133 (16) 0.17195 (16) 0.51850 (13) 0.0418 (4)
C3 0.42669 (17) 0.26374 (17) 0.34806 (14) 0.0438 (4)
C4 0.37290 (17) 0.38287 (17) 0.36542 (14) 0.0460 (4)
C5 0.3446 (2) 0.49234 (19) 0.28137 (16) 0.0529 (4)
H5A 0.4150 0.4980 0.2642 0.063*
H5B 0.3424 0.5733 0.3173 0.063*
C6 0.2176 (2) 0.4763 (2) 0.17021 (19) 0.0625 (5)
H6A 0.1478 0.4628 0.1872 0.075*
H6B 0.2225 0.4002 0.1300 0.075*
supporting information
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C7 0.1865 (3) 0.5949 (3) 0.0927 (2) 0.0891 (8)
H7A 0.1054 0.5816 0.0229 0.134*
H7B 0.2547 0.6076 0.0746 0.134*
H7C 0.1800 0.6702 0.1317 0.134*
C8 0.22523 (18) 0.47959 (18) 0.57142 (16) 0.0489 (4)
C9 0.1270 (2) 0.3881 (2) 0.53692 (18) 0.0586 (5)
H9A 0.0937 0.3477 0.4657 0.070*
C10 0.0791 (2) 0.3573 (2) 0.6090 (2) 0.0669 (6)
H10A 0.0149 0.2941 0.5866 0.080*
C11 0.1244 (2) 0.4185 (3) 0.7138 (2) 0.0694 (6)
C12 0.2192 (2) 0.5123 (3) 0.74454 (19) 0.0720 (6)
H12A 0.2485 0.5565 0.8136 0.086*
C13 0.2718 (2) 0.5423 (2) 0.67553 (18) 0.0587 (5)
H13A 0.3376 0.6040 0.6990 0.070*
C14 0.0734 (3) 0.3817 (4) 0.7929 (3) 0.1124 (13)
H14A 0.0086 0.3151 0.7575 0.169*
H14B 0.0353 0.4564 0.8074 0.169*
H14C 0.1438 0.3501 0.8643 0.169*
H2N2 0.483 (2) 0.096 (2) 0.4206 (19) 0.055 (6)*
H1N1 0.3791 (19) 0.291 (2) 0.5883 (19) 0.046 (5)*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
S1 0.0879 (4) 0.0444 (3) 0.0701 (4) 0.0183 (2) 0.0541 (3) 0.0103 (2)
O1 0.0977 (10) 0.0498 (7) 0.0494 (7) 0.0248 (7) 0.0507 (7) 0.0134 (6)
N1 0.0588 (8) 0.0447 (8) 0.0356 (7) 0.0101 (6) 0.0303 (6) 0.0027 (6)
C1 0.0483 (8) 0.0411 (9) 0.0399 (8) 0.0035 (7) 0.0231 (7) 0.0013 (7)
O2 0.0888 (9) 0.0579 (8) 0.0487 (7) 0.0058 (7) 0.0494 (7) 0.0040 (6)
N2 0.0609 (8) 0.0421 (8) 0.0392 (7) 0.0091 (6) 0.0323 (7) 0.0029 (6)
C2 0.0523 (8) 0.0434 (9) 0.0335 (7) 0.0081 (7) 0.0243 (7) 0.0018 (7)
C3 0.0545 (9) 0.0461 (9) 0.0367 (8) −0.0002 (7) 0.0271 (7) 0.0009 (7)
C4 0.0560 (9) 0.0443 (9) 0.0414 (8) 0.0019 (7) 0.0270 (7) 0.0026 (7)
C5 0.0677 (11) 0.0465 (9) 0.0514 (10) −0.0021 (8) 0.0348 (9) 0.0033 (8)
C6 0.0705 (12) 0.0537 (11) 0.0591 (12) 0.0046 (9) 0.0291 (10) 0.0076 (9)
C7 0.108 (2) 0.0711 (16) 0.0669 (14) 0.0175 (14) 0.0272 (14) 0.0261 (12)
C8 0.0557 (10) 0.0460 (10) 0.0498 (10) 0.0145 (7) 0.0299 (8) 0.0031 (7)
C9 0.0604 (11) 0.0551 (11) 0.0600 (11) 0.0097 (9) 0.0298 (9) −0.0052 (9)
C10 0.0603 (11) 0.0616 (12) 0.0860 (15) 0.0110 (9) 0.0417 (11) 0.0096 (11)
C11 0.0625 (12) 0.0885 (16) 0.0680 (13) 0.0275 (12) 0.0407 (11) 0.0210 (12)
C12 0.0752 (14) 0.0937 (17) 0.0485 (11) 0.0216 (13) 0.0318 (10) −0.0030 (11)
C13 0.0596 (11) 0.0623 (12) 0.0544 (11) 0.0090 (9) 0.0285 (9) −0.0054 (9)
C14 0.099 (2) 0.167 (4) 0.102 (2) 0.038 (2) 0.0731 (19) 0.044 (2)
Geometric parameters (Å, º) 
S1—C1 1.7658 (17) C6—H6B 0.9700
S1—C8 1.7766 (19) C7—H7A 0.9600
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O1—C2 1.225 (2) C7—H7B 0.9600
N1—C2 1.361 (2) C7—H7C 0.9600
N1—C1 1.378 (2) C8—C13 1.379 (3)
N1—H1N1 0.79 (2) C8—C9 1.385 (3)
C1—C4 1.350 (2) C9—C10 1.378 (3)
O2—C3 1.220 (2) C9—H9A 0.9300
N2—C2 1.358 (2) C10—C11 1.381 (4)
N2—C3 1.382 (2) C10—H10A 0.9300
N2—H2N2 0.84 (3) C11—C12 1.378 (4)
C3—C4 1.454 (2) C11—C14 1.508 (3)
C4—C5 1.509 (2) C12—C13 1.383 (3)
C5—C6 1.509 (3) C12—H12A 0.9300
C5—H5A 0.9700 C13—H13A 0.9300
C5—H5B 0.9700 C14—H14A 0.9600
C6—C7 1.526 (3) C14—H14B 0.9600
C6—H6A 0.9700 C14—H14C 0.9600
C1—S1—C8 104.50 (8) C6—C7—H7A 109.5
C2—N1—C1 122.71 (14) C6—C7—H7B 109.5
C2—N1—H1N1 114.1 (16) H7A—C7—H7B 109.5
C1—N1—H1N1 122.9 (16) C6—C7—H7C 109.5
C4—C1—N1 121.90 (15) H7A—C7—H7C 109.5
C4—C1—S1 119.78 (13) H7B—C7—H7C 109.5
N1—C1—S1 118.30 (12) C13—C8—C9 120.23 (19)
C2—N2—C3 126.53 (15) C13—C8—S1 117.82 (16)
C2—N2—H2N2 114.9 (16) C9—C8—S1 121.72 (15)
C3—N2—H2N2 118.3 (16) C10—C9—C8 119.5 (2)
O1—C2—N2 122.78 (15) C10—C9—H9A 120.3
O1—C2—N1 122.06 (14) C8—C9—H9A 120.3
N2—C2—N1 115.16 (14) C9—C10—C11 121.3 (2)
O2—C3—N2 119.25 (16) C9—C10—H10A 119.3
O2—C3—C4 125.16 (16) C11—C10—H10A 119.3
N2—C3—C4 115.59 (14) C12—C11—C10 118.1 (2)
C1—C4—C3 117.98 (15) C12—C11—C14 121.2 (3)
C1—C4—C5 124.38 (16) C10—C11—C14 120.8 (3)
C3—C4—C5 117.64 (15) C11—C12—C13 121.8 (2)
C4—C5—C6 113.39 (16) C11—C12—H12A 119.1
C4—C5—H5A 108.9 C13—C12—H12A 119.1
C6—C5—H5A 108.9 C8—C13—C12 119.0 (2)
C4—C5—H5B 108.9 C8—C13—H13A 120.5
C6—C5—H5B 108.9 C12—C13—H13A 120.5
H5A—C5—H5B 107.7 C11—C14—H14A 109.5
C5—C6—C7 111.6 (2) C11—C14—H14B 109.5
C5—C6—H6A 109.3 H14A—C14—H14B 109.5
C7—C6—H6A 109.3 C11—C14—H14C 109.5
C5—C6—H6B 109.3 H14A—C14—H14C 109.5
C7—C6—H6B 109.3 H14B—C14—H14C 109.5
H6A—C6—H6B 108.0
supporting information
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C2—N1—C1—C4 −2.7 (3) N2—C3—C4—C5 178.08 (16)
C2—N1—C1—S1 179.11 (13) C1—C4—C5—C6 −99.1 (2)
C8—S1—C1—C4 162.19 (15) C3—C4—C5—C6 80.5 (2)
C8—S1—C1—N1 −19.57 (16) C4—C5—C6—C7 174.6 (2)
C3—N2—C2—O1 175.69 (18) C1—S1—C8—C13 123.21 (15)
C3—N2—C2—N1 −3.8 (3) C1—S1—C8—C9 −62.23 (17)
C1—N1—C2—O1 −176.24 (17) C13—C8—C9—C10 −2.0 (3)
C1—N1—C2—N2 3.3 (2) S1—C8—C9—C10 −176.42 (15)
C2—N2—C3—O2 −176.34 (17) C8—C9—C10—C11 1.8 (3)
C2—N2—C3—C4 3.4 (3) C9—C10—C11—C12 0.3 (3)
N1—C1—C4—C3 2.1 (3) C9—C10—C11—C14 −178.5 (2)
S1—C1—C4—C3 −179.72 (13) C10—C11—C12—C13 −2.2 (3)
N1—C1—C4—C5 −178.32 (17) C14—C11—C12—C13 176.6 (2)
S1—C1—C4—C5 −0.1 (2) C9—C8—C13—C12 0.1 (3)
O2—C3—C4—C1 177.39 (17) S1—C8—C13—C12 174.76 (16)
N2—C3—C4—C1 −2.3 (2) C11—C12—C13—C8 2.0 (3)
O2—C3—C4—C5 −2.2 (3)
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A
N2—H2N2···O1i 0.84 (2) 1.98 (2) 2.815 (2) 173 (2)
N1—H1N1···O2ii 0.79 (2) 2.17 (2) 2.8988 (18) 155 (2)
Symmetry codes: (i) −x+1, −y, −z+1; (ii) x, −y+1/2, z+1/2.
